170 related articles for article (PubMed ID: 31546024)
21. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
Tian B; Lu ZN; Guo XL
Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
[TBL] [Abstract][Full Text] [Related]
22. Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.
Lee D; Zhang MS; Tsang FH; Bao MH; Xu IM; Lai RK; Chiu DK; Tse AP; Law CT; Chan CY; Yuen VW; Chui NN; Ng IO; Wong CM; Wong CC
Hepatology; 2021 Aug; 74(2):776-796. PubMed ID: 33619771
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
24. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
25. Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma.
Yang C; Tan YX; Yang GZ; Zhang J; Pan YF; Liu C; Fu J; Chen Y; Ding ZW; Dong LW; Wang HY
J Exp Med; 2016 May; 213(5):859-75. PubMed ID: 27091842
[TBL] [Abstract][Full Text] [Related]
26. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
27. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Sanghvi VR; Leibold J; Mina M; Mohan P; Berishaj M; Li Z; Miele MM; Lailler N; Zhao C; de Stanchina E; Viale A; Akkari L; Lowe SW; Ciriello G; Hendrickson RC; Wendel HG
Cell; 2019 Aug; 178(4):807-819.e21. PubMed ID: 31398338
[TBL] [Abstract][Full Text] [Related]
28. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
Lee D; Xu IM; Chiu DK; Leibold J; Tse AP; Bao MH; Yuen VW; Chan CY; Lai RK; Chin DW; Chan DF; Cheung TT; Chok SH; Wong CM; Lowe SW; Ng IO; Wong CC
Hepatology; 2019 Apr; 69(4):1768-1786. PubMed ID: 30561826
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
[TBL] [Abstract][Full Text] [Related]
30. Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.
Yu JI; Choi C; Shin SW; Son A; Lee GH; Kim SY; Park HC
Sci Rep; 2017 Nov; 7(1):14986. PubMed ID: 29118323
[TBL] [Abstract][Full Text] [Related]
31. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
32. Disruption of De Novo Serine Synthesis in Müller Cells Induced Mitochondrial Dysfunction and Aggravated Oxidative Damage.
Zhang T; Gillies MC; Madigan MC; Shen W; Du J; Grünert U; Zhou F; Yam M; Zhu L
Mol Neurobiol; 2018 Aug; 55(8):7025-7037. PubMed ID: 29383682
[TBL] [Abstract][Full Text] [Related]
33. [The Experiment Study and Mechanism of Aspirin Enhances Cellular Sensitivity of Hepatocellular Carcinoma Cell Line to Arsenic Trioxide].
Hu YN; Gu SY; Zhang ZZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):159-63. PubMed ID: 27263286
[TBL] [Abstract][Full Text] [Related]
34. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells.
Sun Q; Zhang Z; Lu Y; Liu Q; Xu X; Xu J; Liu Y; Yu H; Yu D; Sun B
Hepatology; 2020 Jun; 71(6):2033-2049. PubMed ID: 31578733
[TBL] [Abstract][Full Text] [Related]
35. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.
Liu J; Tao X; Zhang J; Wang P; Sha M; Ma Y; Geng X; Feng L; Shen Y; Yu Y; Wang S; Fang S; Shen Y
Oncotarget; 2016 Apr; 7(16):22206-18. PubMed ID: 26993772
[TBL] [Abstract][Full Text] [Related]
36. CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis.
Wang F; Zhao W; Gao Y; Zhou J; Li H; Zhang G; Guo D; Xie C; Li J; Yin Z; Zhang J
J Exp Clin Cancer Res; 2019 Jul; 38(1):286. PubMed ID: 31272499
[TBL] [Abstract][Full Text] [Related]
37. Fumonisin B
Arumugam T; Pillay Y; Ghazi T; Nagiah S; Abdul NS; Chuturgoon AA
Mycotoxin Res; 2019 Feb; 35(1):99-109. PubMed ID: 30411198
[TBL] [Abstract][Full Text] [Related]
38. Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression.
Jiang C; Zhang C; Dai M; Wang F; Xu S; Han D; Wang Y; Cao Y; Liang Y; Zhang Z; Yan L; Shen Y; He K; Shen Y; Liu J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119595. PubMed ID: 37730133
[TBL] [Abstract][Full Text] [Related]
39. AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550.
Joo MS; Kim WD; Lee KY; Kim JH; Koo JH; Kim SG
Mol Cell Biol; 2016 Jul; 36(14):1931-42. PubMed ID: 27161318
[TBL] [Abstract][Full Text] [Related]
40. Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance.
Schultheis J; Beckmann D; Mulac D; Müller L; Esselen M; Düfer M
Oxid Med Cell Longev; 2019; 2019():7518510. PubMed ID: 31827698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
